AzTrials
AzTrials

Knee AspirationNCT00888368

Accuracy of the Transpatellar Tendon Approach to Knee Arthrocentesis

A study testing Transpatellar Approach and Suprapatellar in people with Knee Aspiration, run by Denver Health and Hospital Authority at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is: To determine the accuracy of intraarticular placement with the transpatellar tendon approach as compared to the suprapatellar approach. Patients undergoing knee arthroscopy will be consented for study of the injection of the fluid into the joint prior to portal placement or commencement… Read more about this study

Who is it for?
Ages 18 to 80 years
Conditions the study is for
Knee Aspiration
What is being tested?
Transpatellar Approach and Suprapatellar
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
1 siteUnited States
Study dates
Jan 2008to Aug 2009
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • undergoing elective arthroscopic surgery of the knee
  • age greater than 18 years old and less than 80 years old
  • able to consent to a research study

Who cannot join

  • allergy to contrast dye, iodine or shellfish
  • currently pregnant
  • acute fracture or dislocation

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Denver Health Medical Center

    Denver, Colorado, 80204

Other trials in United States

About this study

The purpose of this study is:

  • To determine the accuracy of intraarticular placement with the transpatellar tendon approach as compared to the suprapatellar approach. Patients undergoing knee arthroscopy will be consented for study of the injection of the fluid into the joint prior to portal placement or commencement of knee replacement. Patients will be randomized to receive injections via the transpatellar tendon or superolateral approach. Using injectable contrast and fluoroscopy, the placement of injections into the knee will be evaluated for accuracy. Injection attempts with contrast fluid that uniformly coats the articular surface on sagittal and coronal radiographs will be counted as successful. A concentration of contrast fluid in extraarticular fat will be counted as a failure.
Read more

Hypothesis: The rate of accuracy of intraarticular placement of the needle tip via the transpatellar tendon approach to knee aspiration is greater than that of the superolateral approach.

  • To determine the distribution of contrast material with the transpatellar tendon and superolateral apporaches. Using a previously described evaluation technique of dividing the knee into seven compartments, sagittal and coronal fluoroscopy images will be evaluated to determine the distribution of contrast fluid.

Hypothesis: Contrast injected into the knee via the trasnpatellar tendon approach will penetrate as many compartments of the knee as contrast injected via the superolateral approach.

Conditions
Knee Aspiration
Being tested
Transpatellar Approach, Suprapatellar

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Transpatellar ApproachProcedure or surgery

    The transpateller approach for the injection of the dye will be used.

  • SuprapatellarProcedure or surgery

    The suprapatellar approach will be used for the injection of the dye.

Study groups in NCT00888368
Study groupRoleWhat they receive
Transpatellar ApproachExperimentalNot described
Receives: Procedure: Transpatellar Approach
Suprapatellar ApproachActive comparatorNot described
Receives: Procedure: Suprapatellar

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The development of an easier approach to aspirating the knee may lead to improved accuracy of intraarticular needle placement by less experienced practitioners and more "anatomically difficult" knees.

    Measured: 1 time (intraop)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Apr 2009 (estimated)
  2. Study startJan 2008
  3. Primary completionAug 2009
  4. Study completionAug 2009

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
20 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00888368
Sponsor's protocol ID
DHMC07-0387
Status last verified
Jul 2012
First submitted
23 Apr 2009
Last updated
13 Jul 2012
Results posted
No

Questions about this trial

What is this clinical trial studying?

A study testing Transpatellar Approach and Suprapatellar in people with Knee Aspiration, run by Denver Health and Hospital Authority at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 13 Jul 2012. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The development of an easier approach to aspirating the knee may lead to improved accuracy of intraarticular needle placement by less experienced practitioners and more "anatomically difficult" knees. (time frame: 1 time (intraop)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Jul 2012.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in